The relation of the anti-cancer drug resistance and heat shock protein 60 expression
The relation of the anti-cancer drug resistance and heat shock protein 60 expression
批准号:
07671826
负责人:
KIMURA Eizo
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
60 kDa热休克蛋白(HSP60)的表达在卵巢癌患者中差异显著,高水平的表达预示着接受顺铂(DDP)化疗方案治疗的此类患者的生存率较低。我研究了HSP60在人卵巢癌2008细胞和11倍顺铂耐药亚系2008/C13<;D15.25中的表达。在44゚C加热2小时,得到2.7(]sy.+-。[)增长0.16倍(平均()SY+-。[SD]),在热暴露后4h达到最大。暴露于IC50浓度的顺铂1h,可诱发1.8(]sy.+-。[]Hsp60的表达增加0.03倍。镉和锌的情况正好相反,两者都能诱导金属硫蛋白IIA的增加,但在HSP60信息中不会。2008/C13<;d1**@>;D15.25细胞Hsp60mR-NA高表达1.7(]sy+-)。[)0.16目,含3.8(]sy.+-。[]免疫细胞化学染色检测到的HSP60水平高0.45倍。2008/C13<;d1**@>;D15.25细胞对热杀灭表现出1.2倍的交叉抗性。与在体外生长的2008细胞相比,HSP60在2008年异种移植中的表达显著降低;然而,血清饥饿和重新喂养都不会改变该消息的水平。暴露于各种已知可改变2008细胞对DDP敏感性的生长因子和药物治疗,包括表皮生长因子、12-O-十四酰佛波醇-13-乙酸酯、丁硫氨酸亚磺胺、哇巴因和Forsklin,不会改变Hsp60的表达。这些结果提示HSP60在介导对DDP和高温的抵抗中起作用,但表明HSP60的mRNA水平不受上述因素的调节。
英文摘要
The expression of the 60-kDa heat-shock protein (HSP60) varies markedly among pateints with ovarian carcinoma, and high-level expression predicts poor survival in such patients treated with cisplatin (DDP)-containing chemotherapy programs. I investigated the expression of HSP60 in human ovarian carcinoma 2008 cells and an 11-fold DDP-resistant subline 2008/C13<@D1**@>D15.25. Heating for 2 h at 44゚C produced a 2.7(]SY.+-。[)0.16-fold increase (mean (]SY.+-。[)SD) that was maximal at 4 h after the start of heat exposure. Exposure to an IC50 concentration of DDP for 1 h induced a 1.8(]SY.+-。[)0.03-fold increase in hsp60 expression. The opposite was true for cadmimum and zinc, both of which induced increases in metallothionein IIA but not in the hsp60 message. 2008/C13<@D1**@>D15.25 cells cnstitutively overexpressed hsp60 mRNA by 1.7(]SY.+-。[)0.16 orders of magmitude and contained a 3.8(]SY.+-。[)0.45-fold higher level of HSP60as detected by immunocytochemical satining. 2008/C13<@D1**@>D15.25 cells showed 1.2-fold cross-resistance to thermal killing. Expression of hsp60 was markedly reducedin 2008 xenografts as compared with 2008 cells growing in-vitro ; however, neither serum starvation nor refeeding altered the message level. Exposure to a variety of growth factor and drug treatments known to alter the DDP sensitivity of2008 cells, including epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, buthionine sulfoximine, ouabain, and forskolin, did not alter hsp60 expression. These results suggest a role for HSP60 in mediating resistance to both DDP and hyperthermia but indicate that the hsp60 mRNA levels are not regulated by the factors listed above.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Yoshihiro Kikuchi(Ed.): "The Mechanism of Cisplatin Resistance and its Circumvention" Nova Science Publishers,Inc. (in print), (1998)
Yoshihiro Kikuchi(主编):《顺铂耐药机制及其规避》Nova Science Publishers,Inc.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshihiro Kikuchi(Ed.): "The Mechanism of Cisplatin Resistance and its Circumvention" Nova Science Publishers,Inc.(in print), (1998)
Yoshihiro Kikuchi(主编):“顺铂耐药机制及其规避”Nova Science Publishers, Inc.(印刷版),(1998 年)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
国内基金
海外基金
加热治癌(HYPERTHERMIA)中体内功率场分布的研究
-
批准号:38770610
-
项目类别:面上项目
-
资助金额:3.0万元
-
批准年份:1987
-
负责人:宗孔德
-
依托单位: